Clinical Trial Risks
Richard discusses the complexities of clinical trial risks, emphasizing the importance of patient selection and trial design in determining success. He highlights how the board plays a critical role in managing science risk and prioritizing projects, especially when faced with the temptation to explore multiple disease areas simultaneously. Understanding these dynamics is essential for effective investment in biotech.In this clip
From this podcast
The Hard Part with Evan McCann
Richard Waines from DCVC Bio
Related Questions